missing the headsman
My old company just axed another quarter of their staff during the weekly meeting this afternoon. It was an unpleasant surprise to most of the assembled staff, and apparently the CEO was too craven a coward to make the announcement himself this time. I am rapidly running out of people that I met there who still work there. This is their third round of layoffs, and each one has cut staff by at least twenty percent. This does not bode well for the future of the company, but I suppose that they are slimming the workforce in order to concentrate all of their diminishing resources on one of their three drug candidates currently in clinical trials.
Once again, I must reflect and recognize that I am lucky to have left when I did. I almost certainly would have been fired in the first round; I was in a superfluous and overstaffed department, and was a malcontent and rabble-rouser. I do wish that it hadn't unemployed so many of my friends quite so suddenly.
I wish them all the best on their roads ahead, and I even hope that the company does survive this latest downturn. Whatever reservations I have about the conduct of certain scientists employed there or the management team, the biochemistry recorded was amazing in its breadth and depth. Many of their drug targets show incredible promise as treatments for debilitating and terrible diseases, and I suspect that given sufficient time and resources, Lexicon will eventually produce a product of note and value.